CROI 2020 Program and Conference Information

Poster Sessions

F. NEUROPATHOGENESIS AND NEUROLOGIC COMPLICATIONS P-F01 NEUROIMAGING AND ASSOCIATED BIOMARKERS (Monday in Poster Hall A) P-F02 NEUROCOGNITION: BIOMARKERS, THERAPIES, AND OUTCOMES (Tuesday in Poster Hall A) P-F03 CNS RESERVOIRS, ESCAPE, AND IMMUNOLOGY (Tuesday in Poster Hall A) P-F04 ACUTE HIV INFECTION AND CNS RESPONSES (Wednesday in Poster Hall A) P-F05 ART RESPONSES, SWITCHES, AND TOXICITY RELEVANT TO THE CNS (Wednesday in Poster Hall A) G. CLINICAL PHARMACOLOGY P-G01 NOVEL MEASURES OF DRUG ADHERENCE (Monday in Poster Hall A) P-G02 WHAT'S NEW IN DRUG INTERACTIONS (Monday in Poster Hall A) P-G03 PHARMACOKINETICS AND PHARMACODYNAMICS IN SPECIAL POPULATIONS AND BODY SITES (Tuesday in Poster Hall A) P-G04 THE LONG AND THE SHORT OF IT: WHAT IS NEXT FOR LONG ACTINGS (Wednesday in Poster Hall A) H. ANTIRETROVIRAL THERAPY: PRE-CLINICAL DATA, RANDOMIZED TRIALS, EFFICACY AND EFFECTIVENESS STUDIES P-H01 ANTIRETROVIRAL THERAPY: OUTCOMES IN TREATMENT NAIVE-PATIENTS (Monday in Poster Hall A) P-H02 TO THREE OR NOT TO THREE, THAT IS THE QUESTION (Tuesday in Poster Hall A) P-H03 ADHERENCE ASSESSMENT AND OTHER ART STRATEGIES (Tuesday in Poster Hall A) P-H04 ANTIRETROVIRAL TREATMENT: NEW AGENTS, NEW TARGETS (Wednesday in Poster Hall A) I. HIV DRUG RESISTANCE P-I01 PREVALENCE OF PRETREATMENT RESISTANCE (Monday in Poster Hall A) P-I02 DRIVERS OF VIROLOGIC FAILURE AND RESISTANCE EMERGENCE ON EARLY LINES OF THERAPY (Monday in Poster Hall A) P-I03 DRUG RESISTANCE IN EXPERIENCED AND POTENTIAL FOR SUCCESSFUL TREATMENT (Tuesday in Poster Hall A) P-I04 NOVEL MECHANISMS OF DRUG RESISTANCE AND RESISTANCE TO NEW AGENTS (Wednesday in Poster Hall A) P-I05 DRUG RESISTANCE IN SPECIAL POPULATIONS (Wednesday in Poster Hall A) J. HEPATITIS VIRUSES AND LIVER COMPLICATIONS P-J01 HCV: HEPATIC STEATOSIS AND ITS COMPLICATIONS (Monday in Poster Hall B) P-J02 HCV: FIBROSIS, MORTALITY, AND OTHER LONG-TERM COMPLICATIONS (Monday in Poster Hall B) P-J03 RESISTANCE TO HCV DRUGS (Tuesday in Poster Hall B) P-J04 RESISTANCE TO PAYING FOR HCV DRUGS (Tuesday in Poster Hall B) P-J05 HCV THERAPEUTICS: GETTING REAL (Tuesday in Poster Hall B) P-J06 HCV AFTER THE SVR: GONE BUT NOT FORGOTTEN (Tuesday in Poster Hall B) P-J07 HCV EPIDEMIOLOGY: TESTING, TRANSMISSION, AND TRANSMISSION COCONSPIRATORS (Wednesday in Poster Hall B) P-J08 HBV: PATHOGENESIS, EPIDEMIOLOGY, PREVENTION, AND THERAPY (Wednesday in Poster Hall B) P-J09 HAV AND HEV (Wednesday in Poster Hall B) K. AIDS-RELATEDMALIGNANCIES P-K01 ANAL AND CERVICAL CANCER (Monday in Poster Hall B) P-K02 CANCERS: KAPOSI SARCOMA, LUNG, BREAST, AND HEMATOLOGIC (Tuesday in Poster Hall B) P-K03 CANCER TREATMENT AND RISK (Wednesday in Poster Hall B)

Poster Sessions

CROI 2020 174